Note for the rapporteurs/shadow rapporteurs of the EU Pharmaceutical legislation: Impact of extending the duration of regulatory data protection in the new EU pharmaceutical legislation

7 December 2023

Policy

A Fair and Balanced System for Unitary Supplementary Protection Certificates (SPCs) and Centralised Procedure for Granting National SPCs in the European Union

13 November 2023

Policy

Time for an EU action on equal access: No more delays for patients!

10 November 2023

Policy

Why Clarification & Harmonisation of the Bolar Exemption and an Explicit Prohibition of Patent Linkage Is Needed in the European Union

31 October 2023

Policy

IQVIA – Assessing the Biosimilar Void

30 October 2023

External Resource

While biosimilar competition in Europe has played a vital role […]

Review of Nitrosamine Drug Substance Related Impurities (NDSRI) in Pharmaceutical Drugs

30 October 2023

Report

European strategic stockpile

11 October 2023

Factsheet

Market review Biosimilar medicines policy 2023 – Policy Statement

27 September 2023

Policy

Biosimilars Market Review 2023

18 September 2023

Report

Market review Generic medicines policy 2023 – Policy Statement

29 June 2023

Policy